Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Pre-Tax Margin

144.43%

Quarterly · Period ending:

LCTX logo

LCTX Pre-Tax Margin

Latest reported144.43%
LCTX Quarterly Pre-Tax Margin (0.00% → 144.43%)
High-resolution chart · PNG

LCTX pre-tax margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Pre-Tax Margin — Quarterly
Period endingPre-Tax Margin
144.4341%
-277.6232%
-66.4044%
-808.2586%
-1,098.1555%
-275.8322%
-113.3194%
-79.4125%
-410.0142%
-454.1551%
-225.7663%
-574.4783%
-161.3333%
-260.1425%
-332.2193%
-185.9573%
-148.9567%
-135.4401%
-2,917.6042%
-401.7257%
-1,125.8503%
-494.198%
592.7711%
-2,324.5614%
-6,595.9596%
-5,077.1084%
-641.8269%
-8,067.2811%
-12,520%
19,503.9106%
-26,508.7719%
25,206.0606%
-766.6667%
-16,986.1333%
-13,505.0967%
4,051.4039%
-4,226.7717%
13,430.343%
-1,021.2401%
7,503.8462%
4,194.664%
-4,095.0512%
-3,229.9099%
-2,105.8333%
-2,319.4056%
-2,433.9766%
-3,371.4807%
-2,256.4179%
-2,765.7824%
-2,256.13%
-2,327.526%
-1,852.5549%
-1,567.5034%
-1,604.2341%
-1,380.2441%
-590.8263%
-580.2289%
-987.8431%
-335.0505%
-370.895%
-656.0159%
-468.2943%
-253.6201%
-301.4537%
-345.989%
-167.7381%
233.2473%
-653.4982%
-255.9261%
-306.7257%
-1,325.3277%
-252.311%
-161.432%
-124.9411%
-401.1531%
-92.3568%
-163.2701%
-225.4239%
-388.3964%
-114.4914%
0%
-197.8088%
-184.7453%
-172.6301%
0%
-380.2484%
-311.3019%
-236.2599%
-226.4128%
-1,257.0329%
-144.6698%
329.4985%
-773.253%
-694.5923%
-1,243.4336%
0%
-933.7499%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.